A Pilot Study to Assess Transfusion Transmission of Hepatitis C Virus
Tóm tắt
Alexandria University blood bank adopted double screening tests: a fully automated chemiluminescence immunoassay followed by nucleic acid testing. The aim of the study was to assess the efficiency of dual check of HCV in preventing transfusion related infection among patients admitted to PICU. A prospective cohort study was carried on patients admitted to PICU during 6 months. The included patients performed HCV RNA detection on admission by conventional reverse transcriptase polymerase chain reaction (RT-PCR) technique. Only negative cases were recruited, then patients receiving blood or its product were checked after 4 weeks from discharge by RT-PCR for HCV RNA. A total of 33 patients received 108 transfusions: 9 patients of them deceased during PICU stay and the remaining 24 patients were all found to be negative for HCV. The dual screening of HCV should be implemented in all blood banks of Egypt especially for critically ill pediatric patients.
Tài liệu tham khảo
Mahmoud YA, Mumtaz GR, Riome S et al (2013) The epidemiology of hepatitis C virus in Egypt: a systematic review and data analysis. BMC Infect Dis 13:288
Denniston MM, Jiles RB, Drobeniuc J et al (2014) Chronic hepatitis C virus infection in the United States, National health and nutrition survey. Ann Intern Med 160:293–300
Hladik W, Kataaha P, Mermin J et al (2006) Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 11:951–954
Lerat H, Blaine HF (2004) HCV occult infection or occult HCV RNA detection. J Infect Dis 1:3–6
Busch MP, Rawal BD, Feibig EW et al (1998) Dynamics of HCV viremia and seroconversion in transfusion-acquired HCV infections. Transfusion 38:72s
Takamizawa A, Mori C, Fuke I et al (1991) Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105–1113
Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:606–616
Marwaha N, Sachdev S (2015) Current testing strategies for hepatitis C virus infection in blood donors and the way foreword. World J Gastroenterol 21(43):12510–12512
Omran D, Hussein AE, Nagib M (2013) Safety of blood transfusion: an Egyptian study. J Infect Dis Ther 2(1):1–124
Abdelrazik AM, Ezzat GM (2016) Priority needs and wisdom strategy for blood transfusion safety in developing low resource countries. Transfus Apheresis Sci 54:147–9
Halfon P, Bourlière M, Pénaranda G et al (2006) Real-time PCR assays for hepatitis C Virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J Clin Microbiol 44(7):2507–11
Chaurasia R, Rout D, Zaman S et al (2016) Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT assays for screening of transfusion transmitted infections among blood donors in India. Int J Microbiol. https://doi.org/10.1155/2016/2543156
Zou S, Dorsey KA, Notari EP et al (2010) Prevalence, incidence and residual risk of HIV and HCV infections among US blood donors since the introduction of NAT. Transfusion 50(7):1495–1504
Weusten J, Vermeulen M, van Drimmelen H et al (2011) Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by NAT in different pool sizes and repeat test algorithms. Transfusion 51:203–215
Kouyoumjian SP, Chemaitelly H, Abu-Raddad LJ (2018) Characterizing HCV epidemiology in Egypt: systematic review, meta-analysis, and meta-regression. Nat Sci Rep. https://doi.org/10.1038/s41598-017-17936-4